SPL 2.11% 9.3¢ starpharma holdings limited

Ann: VivaGel BV NDA advances to next stage of FDA review, page-14

  1. 15,510 Posts.
    lightbulb Created with Sketch. 5586
    I think you will find that because VivaGel® BV was granted both QIDP and Fast Track status by the FDA that it will be through this year .... let's hope

    ... someone a few months back gave an example on here of another NDA, which was approved in 3-4 months from submission .... if that person could re-post this information that would be appreciated as I searched but could not find it !

    ..... oh and good to see that we have been in the top 5 HC posts on front page for a few hours ... keep clicking the thumbs up people
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.